{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:25:59Z","timestamp":1790735159200,"version":"4.1.0"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56- AI103382-01A1"],"award-info":[{"award-number":["R56- AI103382-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21-AI094402-01"],"award-info":[{"award-number":["R21-AI094402-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21-AI095718-01"],"award-info":[{"award-number":["R21-AI095718-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154819","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:34:41Z","timestamp":1461951281000},"page":"e0154819","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine"],"prefix":"10.1371","volume":"11","author":[{"given":"Jairo Andres","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cabrera-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Van Pelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"ref1","article-title":"World malaria report 2014","year":"2014"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid2110.150682","article-title":"Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure","volume":"21","author":"S Menard","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"WorldWide Antimalarial Resistance Network Lumefantrine PKPDSG. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","year":"2015","journal-title":"BMC Med"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/ecp.13.17","article-title":"Emerging artemisinin resistance in the border areas of Thailand","volume":"6","author":"K Na-Bangchang","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"RN Price","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"e1001619","DOI":"10.1371\/journal.pmed.1001619","article-title":"The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis","volume":"11","author":"C Strode","year":"2014","journal-title":"PLOS Med"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jiph.2014.06.002","article-title":"Culminating anti-malaria efforts at long lasting insecticidal net?","volume":"7","author":"S Dhiman","year":"2014","journal-title":"J Infect Public Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2015.06.008","article-title":"Malaria vaccine clinical trials: what's on the horizon","volume":"35","author":"A Moreno","year":"2015","journal-title":"Current opinion in immunology"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2014.03.011","article-title":"Memory T cells maintain protracted protection against malaria","volume":"161","author":"U Krzych","year":"2014","journal-title":"Immunology letters"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/pim.12086","article-title":"Protective immunity against malaria after vaccination","volume":"36","author":"JB de Souza","year":"2014","journal-title":"Parasite Immunol"},{"key":"ref11","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","author":"SCTP Rts","year":"2015","journal-title":"Lancet"},{"issue":"18","key":"ref12","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2008.02.048","article-title":"Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S\/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research","volume":"26","author":"KE Kester","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"KE Kester","year":"2009","journal-title":"The Journal of infectious diseases"},{"issue":"9984","key":"ref14","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"FC Zhu","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1172\/JCI75894","article-title":"HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial","volume":"124","author":"PA Bart","year":"2014","journal-title":"J Clin Invest"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"e106240","DOI":"10.1371\/journal.pone.0106240","article-title":"Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial","volume":"9","author":"UN Sarwar","year":"2014","journal-title":"PLOS one"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"CM Bollard","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"KJ Ewer","year":"2013","journal-title":"Nat Commun"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.4161\/hv.26038","article-title":"Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults","volume":"9","author":"CB Creech","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/imm.12226","article-title":"Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection","volume":"141","author":"SC Elias","year":"2014","journal-title":"Immunology"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"SH Sheehy","year":"2012","journal-title":"Mol Ther"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"e55571","DOI":"10.1371\/journal.pone.0055571","article-title":"DNA prime\/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity","volume":"8","author":"I Chuang","year":"2013","journal-title":"PLOS one"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"e106241","DOI":"10.1371\/journal.pone.0106241","article-title":"Sterile immunity to malaria after DNA prime\/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes","volume":"9","author":"M Sedegah","year":"2014","journal-title":"PLOS one"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"e0131571","DOI":"10.1371\/journal.pone.0131571","article-title":"Ad35.CS.01-RTS,S\/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naive Adults","volume":"10","author":"CF Ockenhouse","year":"2015","journal-title":"PLOS one"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"P Abbink","year":"2007","journal-title":"Journal of virology"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/CVI.00311-10","article-title":"The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert","volume":"17","author":"K Radosevic","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e33920","DOI":"10.1371\/journal.pone.0033920","article-title":"Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses","volume":"7","author":"JT Bruder","year":"2012","journal-title":"PLOS one"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1172\/JCI39812","article-title":"Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice","volume":"120","author":"T Shiratsuchi","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.05980-11","article-title":"A hybrid multistage protein vaccine induces protective immunity against murine malaria","volume":"80","author":"B Singh","year":"2012","journal-title":"Infection and immunity"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.micinf.2005.04.020","article-title":"Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria","volume":"7","author":"I Caro-Aguilar","year":"2005","journal-title":"Microbes Infect"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1128\/IAI.70.7.3479-3492.2002","article-title":"Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens","volume":"70","author":"I Caro-Aguilar","year":"2002","journal-title":"Infection and immunity"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"V Krasnykh","year":"1996","journal-title":"J Virol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","article-title":"Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule","volume":"9","author":"AV Pereboev","year":"2004","journal-title":"Mol Ther"},{"issue":"1","key":"ref34","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr.","year":"1968","journal-title":"Virology"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"N Mittereder","year":"1996","journal-title":"Journal of virology"},{"issue":"14","key":"ref36","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.vaccine.2010.01.019","article-title":"Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate","volume":"28","author":"B Singh","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jcla.20172","article-title":"Improved method to calculate the antibody avidity index","volume":"21","author":"CT Perciani","year":"2007","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection","volume":"13","author":"NS Butler","year":"2012","journal-title":"Nature immunology"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1590\/S0104-11692011000600002","article-title":"Primary health care in municipalities at high risk for malaria","volume":"19","author":"AC Ferreira","year":"2011","journal-title":"Rev Lat Am Enfermagem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"29067","DOI":"10.3402\/gha.v8.29067","article-title":"Behind the scenes of the PRIME intervention: designing a complex intervention to improve malaria care at public health centres in Uganda","volume":"8","author":"DD DiLiberto","year":"2015","journal-title":"Glob Health Action"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/427243","article-title":"Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites","volume":"191","author":"P Bejon","year":"2005","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"MT White","year":"2015","journal-title":"The Lancet Infectious diseases"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/IAI.00442-09","article-title":"Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S\/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique","volume":"77","author":"A Barbosa","year":"2009","journal-title":"Infection and immunity"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"e61395","DOI":"10.1371\/journal.pone.0061395","article-title":"The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection","volume":"8","author":"MT White","year":"2013","journal-title":"PLOS one"},{"key":"ref45","first-page":"41","article-title":"Malaria and the liver: immunological hide-and-seek or subversion of immunity from within?","volume":"6","author":"P Bertolino","year":"2015","journal-title":"Front Microbiol"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"e102225","DOI":"10.1371\/journal.pone.0102225","article-title":"Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination","volume":"9","author":"L Chen","year":"2014","journal-title":"PLOS one"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"e88117","DOI":"10.1371\/journal.pone.0088117","article-title":"CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infection","volume":"9","author":"MD Lewis","year":"2014","journal-title":"PLOS one"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.vaccine.2013.11.058","article-title":"CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii","volume":"32","author":"KL Doll","year":"2014","journal-title":"Vaccine"},{"issue":"38","key":"ref49","doi-asserted-by":"crossref","first-page":"14509","DOI":"10.1073\/pnas.0806727105","article-title":"Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells","volume":"105","author":"RJ Lundie","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals","volume":"211","author":"SH Hodgson","year":"2015","journal-title":"The Journal of infectious diseases"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4161\/hv.24941","article-title":"Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection","volume":"9","author":"C Tamminga","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"e25868","DOI":"10.1371\/journal.pone.0025868","article-title":"Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component","volume":"6","author":"C Tamminga","year":"2011","journal-title":"PLOS one"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp100214b","article-title":"Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach","volume":"8","author":"QL Matthews","year":"2011","journal-title":"Mol Pharm"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JVI.56.2.439-448.1985","article-title":"Molecular composition of the adenovirus type 2 virion","volume":"56","author":"J van Oostrum","year":"1985","journal-title":"Journal of virology"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JVI.79.6.3382-3390.2005","article-title":"Identification of sites in adenovirus hexon for foreign peptide incorporation","volume":"79","author":"H Wu","year":"2005","journal-title":"Journal of virology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1743-422X-5-98","article-title":"Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach","volume":"5","author":"QL Matthews","year":"2008","journal-title":"Virol J"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"e11815","DOI":"10.1371\/journal.pone.0011815","article-title":"HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach","volume":"5","author":"QL Matthews","year":"2010","journal-title":"PLOS one"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1743-422X-11-112","article-title":"A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy","volume":"11","author":"L Gu","year":"2014","journal-title":"Virol J"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1371\/journal.pntd.0003089","article-title":"Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection","volume":"8","author":"AL Farrow","year":"2014","journal-title":"PLOS Negl Trop Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12985-015-0364-7","article-title":"Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach","volume":"12","author":"WH Wu","year":"2015","journal-title":"Virol J"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2015.10.010","article-title":"Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy","volume":"487","author":"L Gu","year":"2015","journal-title":"Virology"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI23135","article-title":"Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid","volume":"115","author":"S Worgall","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"e49607","DOI":"10.1371\/journal.pone.0049607","article-title":"CryoEM visualization of an adenovirus capsid-incorporated HIV antigen","volume":"7","author":"JW Flatt","year":"2012","journal-title":"PLOS one"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/IAI.00480-15","article-title":"Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera","volume":"83","author":"M Cabrera-Mora","year":"2015","journal-title":"Infection and immunity"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"e105828","DOI":"10.1371\/journal.pone.0105828","article-title":"Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*\/DQB1* in malaria exposed individuals from the Brazilian Amazon","volume":"9","author":"AR Ferreira","year":"2014","journal-title":"PLOS one"},{"issue":"8","key":"ref66","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.vaccine.2010.12.040","article-title":"Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice","volume":"29","author":"C Palma","year":"2011","journal-title":"Vaccine"},{"issue":"44","key":"ref67","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2010.08.068","article-title":"Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1","volume":"28","author":"AD Douglas","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1128\/IAI.65.8.3024-3031.1997","article-title":"Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds","volume":"65","author":"A Egan","year":"1997","journal-title":"Infection and immunity"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"N Tatsis","year":"2007","journal-title":"Blood"},{"issue":"7","key":"ref70","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/JVI.01530-06","article-title":"Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy","volume":"81","author":"M Perreau","year":"2007","journal-title":"Journal of virology"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.vaccine.2011.01.022","article-title":"Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine","volume":"29","author":"BN Hangalapura","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"ref72","first-page":"350","article-title":"Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors","volume":"5","author":"M Di Nicola","year":"1998","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/IAI.02626-14","article-title":"A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys","volume":"83","author":"KA Karen","year":"2015","journal-title":"Infection and immunity"},{"issue":"6","key":"ref74","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/CVI.00066-13","article-title":"Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint","volume":"20","author":"MD Porter","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"ref75","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pmed.0020344","article-title":"A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum","volume":"2","author":"P Druilhe","year":"2005","journal-title":"PLOS Med"},{"issue":"Suppl 1","key":"ref76","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: influence on vector function and effector mechanisms","volume":"11","author":"N Bessis","year":"2004","journal-title":"Gene Ther"},{"issue":"9","key":"ref77","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"N Chirmule","year":"1999","journal-title":"Gene Ther"},{"issue":"7","key":"ref78","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.vaccine.2010.12.025","article-title":"Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid","volume":"29","author":"A Lanzi","year":"2011","journal-title":"Vaccine"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"FD Finkelman","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"MJ Boyle","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"ref81","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.20121416","article-title":"PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis","volume":"210","author":"BH Zinselmeyer","year":"2013","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"ref82","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/0008-5472.CAN-14-1215","article-title":"PD-1\/SHP-2 inhibits Tc1\/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment","volume":"75","author":"J Li","year":"2015","journal-title":"Cancer Res"},{"issue":"27","key":"ref83","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"F Wei","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref84","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/CVI.00207-14","article-title":"Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors","volume":"21","author":"JE Teigler","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"18","key":"ref85","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"JE Teigler","year":"2012","journal-title":"Journal of virology"},{"issue":"3","key":"ref86","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"P Penaloza-MacMaster","year":"2013","journal-title":"Journal of virology"},{"issue":"32","key":"ref87","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"DH Barouch","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"ref88","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jgm.1332","article-title":"Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5","volume":"11","author":"S Abe","year":"2009","journal-title":"J Gene Med"},{"issue":"2","key":"ref89","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"RR Bradley","year":"2012","journal-title":"Journal of virology"},{"issue":"15","key":"ref90","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"H Qiu","year":"2012","journal-title":"Journal of virology"},{"issue":"1","key":"ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.07.043","article-title":"Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys","volume":"407","author":"J Ersching","year":"2010","journal-title":"Virology"},{"issue":"12","key":"ref92","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"K McCoy","year":"2007","journal-title":"Journal of virology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T07:31:39Z","timestamp":1600500699000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154819"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154819","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}